Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-19

Clinical Trial Update: The HeartSpare Plus 1B Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update for HeartSpare Plus 1B in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED